Madrigal Pharmaceuticals PEG Ratio

The latest PEG ratio for MDGL is -98.83. That is below the Healthcare sector average of 11.77. Investors often review this figure alongside Madrigal Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, MDGL currently prints -98.83 for PEG ratio, while the sector average sits near 11.77. That is roughly 939.5% below the sector mean. Large gaps often invite a closer look at Madrigal Pharmaceuticals's growth, margins, and balance sheet.

A PEG ratio of -98.83 for Madrigal Pharmaceuticals is not 'good' or 'bad' on its own. Compare it with the peer average (11.77) and with MDGL's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting MDGL's PEG ratio (-98.83), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Madrigal Pharmaceuticals's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.